Primary references
Selected research and references on weight loss, preparation and body contouring. This list includes published work co-authored by Dr. Smith.
Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021;384:989-1002. With the STEP 1 trial extension: Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes Obes Metab 2022;24:1553-1564.
Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA 2024;331:38-48. With Horn DB et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). Lancet 2026;407:2305-2318.
Look M et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes Obes Metab 2025;27:2720-2729. With Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism 2025;164:156113.
Constantine RS, Davis KE, Kenkel JM. The effect of massive weight loss status, amount of weight loss, and method of weight loss on body contouring outcomes. Aesthet Surg J 2014;34:578-583. With Abbott EN et al. Post weight loss body contouring surgery: complication rates following bariatric surgery, injectable glucagon-like peptide-1 receptor agonist pharmacotherapy, combination therapy, and lifestyle modification. Aesthet Surg J 2026;46:1029-1036.
Aschen SZ et al. Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes. Ann Surg 2025;281:600-607.
Elkin J et al. Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis. Anaesthesia 2025;80:846-858. With Ahmad AI et al. Holding vs continuing GLP-1/GIP agonists before upper endoscopy: the OCULUS randomized clinical trial. JAMA Intern Med 2026;186:578-584.
Oprea AD et al. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: SPAQI multidisciplinary consensus statement. Br J Anaesth 2025;135:48-78.
Bruno A, Calicchia A, Schirosi M. Impact of preoperative semaglutide discontinuation timing on postoperative outcomes in aesthetic abdominoplasty. Aesthetic Plast Surg 2026;50:6564-6570.
Alfertshofer M et al. From serum to surgery: the significance of albumin in preoperative risk stratification, an analysis of 200,015 plastic surgery patients. Aesthetic Plast Surg 2026;50:3530-3540. With Austin RE, Lista F, Khan A, Ahmad J. The impact of protein nutritional supplementation for massive weight loss patients undergoing abdominoplasty. Aesthet Surg J 2016;36:204-210.
Hatef DA, Trussler AP, Kenkel JM. Procedural risk for venous thromboembolism in abdominal contouring surgery: a systematic review of the literature. Plast Reconstr Surg 2010;125:352-362. With Rohrich RN et al. Three decades of outpatient plastic surgery safety: a review of 42,720 consecutive cases. Plast Reconstr Surg 2025;156:49-61.
Xia Y, Zhao J, Cao DS. Safety of lipoabdominoplasty versus abdominoplasty: a systematic review and meta-analysis. Aesthetic Plast Surg 2019;43:167-174. With Modarressi A, Meia Ruegg E, Bezzola T, Pittet-Cuenod B. Circular abdominoplasty after massive weight loss: is it a risky procedure? J Plast Reconstr Aesthet Surg 2016;69:1497-1505.
Patane L et al. Safety and efficacy of combining multiple body-contouring procedures in massive-weight-loss patients: a retrospective multicenter study. Aesthetic Plast Surg 2026;50:3690-3699.
Ponzo M, Lombardi M, Santorelli A. Psychosocial outcomes and aesthetic expectations in female patients undergoing body contouring after GLP-1-induced weight loss. Aesthetic Plast Surg 2026;50:6161-6167.
Matarasso A, Smith DM. Strategies for aesthetic reshaping of the postpartum patient. Plast Reconstr Surg 2015;136:245-257.
Bucknor A, et al. National mortality rates after outpatient cosmetic surgery and low rates of perioperative deep vein thrombosis screening and prophylaxis. Plast Reconstr Surg 2018;142:90-98.
Pannucci CJ, Swistun L, MacDonald JK, Henke PK, Brooke BS. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg 2017;265:1094-1103.
Medically reviewed by Darren M. Smith, MD, FACS on October 4, 2026.